| pubmed-article:11851658 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11851658 | lifeskim:mentions | umls-concept:C1273518 | lld:lifeskim |
| pubmed-article:11851658 | lifeskim:mentions | umls-concept:C0026882 | lld:lifeskim |
| pubmed-article:11851658 | lifeskim:mentions | umls-concept:C0012906 | lld:lifeskim |
| pubmed-article:11851658 | lifeskim:mentions | umls-concept:C1947901 | lld:lifeskim |
| pubmed-article:11851658 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:11851658 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:11851658 | pubmed:dateCreated | 2002-2-19 | lld:pubmed |
| pubmed-article:11851658 | pubmed:abstractText | Molecular approaches are increasingly being employed to dissect the genetic changes accompanying tumour formation. These methods can often be confusing to the non-specialist as they include complex molecular steps. This can reduce the usefulness of such molecular data to clinicians. The authors aim to aid interpretation of molecular studies in general by presenting a comprehensive review of one molecular approach, i.e. the use of restriction enzymes in molecular studies of tumour development. | lld:pubmed |
| pubmed-article:11851658 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11851658 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11851658 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11851658 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11851658 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11851658 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:11851658 | pubmed:issn | 0007-1323 | lld:pubmed |
| pubmed-article:11851658 | pubmed:author | pubmed-author:YuJJ | lld:pubmed |
| pubmed-article:11851658 | pubmed:author | pubmed-author:ParryJ MJM | lld:pubmed |
| pubmed-article:11851658 | pubmed:author | pubmed-author:WilliamsG LGL | lld:pubmed |
| pubmed-article:11851658 | pubmed:author | pubmed-author:BaxterJ NJN | lld:pubmed |
| pubmed-article:11851658 | pubmed:author | pubmed-author:BeynonJJ | lld:pubmed |
| pubmed-article:11851658 | pubmed:author | pubmed-author:JenkinsG J... | lld:pubmed |
| pubmed-article:11851658 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11851658 | pubmed:volume | 89 | lld:pubmed |
| pubmed-article:11851658 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11851658 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11851658 | pubmed:pagination | 8-20 | lld:pubmed |
| pubmed-article:11851658 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11851658 | pubmed:meshHeading | pubmed-meshheading:11851658... | lld:pubmed |
| pubmed-article:11851658 | pubmed:meshHeading | pubmed-meshheading:11851658... | lld:pubmed |
| pubmed-article:11851658 | pubmed:meshHeading | pubmed-meshheading:11851658... | lld:pubmed |
| pubmed-article:11851658 | pubmed:meshHeading | pubmed-meshheading:11851658... | lld:pubmed |
| pubmed-article:11851658 | pubmed:meshHeading | pubmed-meshheading:11851658... | lld:pubmed |
| pubmed-article:11851658 | pubmed:meshHeading | pubmed-meshheading:11851658... | lld:pubmed |
| pubmed-article:11851658 | pubmed:meshHeading | pubmed-meshheading:11851658... | lld:pubmed |
| pubmed-article:11851658 | pubmed:meshHeading | pubmed-meshheading:11851658... | lld:pubmed |
| pubmed-article:11851658 | pubmed:meshHeading | pubmed-meshheading:11851658... | lld:pubmed |
| pubmed-article:11851658 | pubmed:meshHeading | pubmed-meshheading:11851658... | lld:pubmed |
| pubmed-article:11851658 | pubmed:meshHeading | pubmed-meshheading:11851658... | lld:pubmed |
| pubmed-article:11851658 | pubmed:meshHeading | pubmed-meshheading:11851658... | lld:pubmed |
| pubmed-article:11851658 | pubmed:year | 2002 | lld:pubmed |
| pubmed-article:11851658 | pubmed:articleTitle | Restriction enzymes in the analysis of genetic alterations responsible for cancer progression. | lld:pubmed |
| pubmed-article:11851658 | pubmed:affiliation | Human Molecular Pathology Group, Swansea Clinical School, University of Wales Swansea, Singleton Park, Swansea, UK. g.j.jenkins@swansea.ac.uk | lld:pubmed |
| pubmed-article:11851658 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11851658 | pubmed:publicationType | Review | lld:pubmed |
| pubmed-article:11851658 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11851658 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11851658 | lld:pubmed |
